Frontiers in Nutrition, 11 , 1337328
Other combinations of entero-pancreatic hormones, including cagrisema (GLP-1/amylin RA) and the triple agonist retatrutide (GLP-1/GIP/glucagon RA), have progressed to phase 3 trials as obesity treatments, and early data suggest that they may lead to even greater weight loss than tirzepatide [28]
Products marketed as "GLP-1 patches" typically contain botanical extracts, amino acids, or vitamins rather than actual GLP-1 receptor agonists
Reduce unhealthy cravings
However, here are some general guidelines on who may qualify for GLP-1 medications: Type 2 Diabetes Diagnosis GLP-1 medications are primarily indicated for the treatment of type 2 diabetes
This finding may also explain the greater glucose-lowering effects of DPP-4 inhibitors in East Asian populations, where saturated fat intake is generally lower than in Western countries [20]